Home > Insider Trading > Filing (0001209191-19-053284)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1661567	Michael Parini	50 Northern Avenue Boston MA 02210	Evp, Cl&Ao	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-10-14	2,125	$90.29	37,128	No	4	M	Direct
Common Stock	Disposition	2019-10-14	889	$173.44	36,239	No	4	S	Direct
Common Stock	Disposition	2019-10-14	1,136	$174.46	35,103	No	4	S	Direct
Common Stock	Disposition	2019-10-14	100	$175.10	35,003	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-10-14	2,125	$0.00	2,125	$90.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,375		2026-07-11	No	4	M	Direct

Footnotes

Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $173.44 (range $172.81 to $173.77).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $174.46 (range $174.07 to $174.90).
The option vests in 16 quarterly installments from 07/12/2016.